Author

R. Brouard

Observed names: BROUARD, Rémi, R Brouard, RJ Brouard, Remi Brouard, Remi J Brouard, Rémi Brouard, Rémi Brouard

Observed institutions: San Francisco General Hospital, University of California, San Francisco, University Hospitals of Cleveland, Western Infirmary, Centre Hospitalier Universitaire Vaudois, Sanofi (France), Centre Hospitalier Universitaire de Toulouse, Hôpital Orthopédique de la Suisse Romande, Hôpital Lariboisière, Pitié-Salpêtrière Hospital, Hôpital Rangueil, Polyclinic Medical University, Hôpital Lapeyronie, Institut de Relations Internationales et Stratégiques, Groupe Hospitalo-Universitaire Paris Nord, Case Western Reserve University, University of Glasgow

OpenAlex ID: A5110133886

Pharmacologic Chaperones as a Potential Treatment for X-Linked Nephrogenic Diabetes Insipidus

2005 · Virginie Bernier, Jean-Pierre Morello, et al. · Journal of the American Society of Nephrology · 248

Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women

1999 · Mats Åkerlund, Thomas Bossmar, et al. · BJOG An International Journal of Obstetrics & Gynaecology · 124

The effect of the NK2 tachykinin receptor antagonist SR 48968 (saredutant) on neurokinin A-induced bronchoconstriction in asthmatics

1998 · J Van Schoor, GF Joos, et al. · European Respiratory Journal · 106

PDF

Short-term and Sustained Renal Effects of Angiotensin II Receptor Blockade in Healthy Subjects

1995 · Michel Burnier, Michael Hagman, et al. · Hypertension · 93

The ATTEMPT cohort: a multi‐national longitudinal study of predictors, patterns and consequences of smoking cessation; introduction and evaluation of internet recruitment and data collection methods

2006 · Robert West, Alicia Gilsenan, et al. · Addiction · 66

Effect of SR49059, an orally active V1a vasopressin receptor antagonist, in the prevention of dysmenorrhoea

2000 · R. Brouard, T. Bossmar, et al. · BJOG An International Journal of Obstetrics & Gynaecology · 62

The effect of relcovaptan (SR 49059), an orally active vasopressin V1areceptor antagonist, on uterine contractions in preterm labor

2005 · Margareta Steinwall, Thomas Bossmar, et al. · Gynecological Endocrinology · 46

Effects of the Nonpeptide V 1 Vasopressin Receptor Antagonist SR49059 in Hypertensive Patients

1999 · Marc Thibonnier, Ahmad Kilani, et al. · Hypertension · 45

Effect of SR 49059, a V1a vasopressin receptor antagonist, in Raynaud's phenomenon

2000 · D. Hayoz, G. Bizzini, et al. · Rheumatology · 29

Dose-Ranging Study of the Angiotensin II Receptor Antagonist Irbesartan (SR 47436/BMS-186295) on Blood Pressure and Neurohormonal Effects in Salt-Deplete Men

1996 · M. McIntyre, R. J. MacFadyen, et al. · Journal of Cardiovascular Pharmacology · 27

Effects of SR 49059, a New Orally Active and Specific Vasopressin V1Receptor Antagonist, on Vasopressin-Induced Vasoconstriction in Humans

1997 · Roger Weber, Antoinette Pechère-Bertschi, et al. · Hypertension · 26

Effects of SR 49059, an orally active V1a vasopressin receptor antagonist, on vasopressin‐induced uterine contractions

1997 · Thomas Bossmar, Rémi Brouard, et al. · BJOG An International Journal of Obstetrics & Gynaecology · 25

PDF

Acute Renal Effects of AT1-Receptor Blockade After Exogenous Angiotensin II Infusion in Healthy Subjects

1998 · Francois Schmitt, Franck Martinez, et al. · Journal of Cardiovascular Pharmacology · 21

Safety, Tolerability, and Pharmacokinetics of SR 49059, a V1A Vasopressin Receptor Antagonist, After Repeated Oral Administration in Healthy Volunteers

1998 · R. Brouard, V. Laporte, et al. · Advances in experimental medicine and biology · 19

A drug interaction study between ticlopidine and cyclosporin in heart transplant recipients

1997 · P. Boissonnat, M. de Lorgeril, et al. · European Journal of Clinical Pharmacology · 18

Transfer of Autologous Haemoglobin from the Peritoneal Cavity During Peritoneal Dialysis

1992 · R. Brouard, T. N. Tozer, et al. · Nephrology Dialysis Transplantation · 17

Role of Acetate in Loss of Ultrafiltration during CAPD

2015 · J. Rottembourg, R. Brouard, et al. · Contributions to nephrology · 16

Erratum: The ATTEMPT cohort: A multi-national longitudinal study of predictors, patterns and consequences of smoking cessation; introduction and evaluation of internet recruitment and data collection methods (Addiction (2006) 101, (1352-1361))

2006 · Robert West, Alicia Gilsenan, et al. · UCL Discovery (University College London) · 15

Teicoplanin pharmacokinetics and bioavailability during peritoneal dialysis

1989 · Remi J Brouard, Joan E Kapusnik, et al. · Clinical Pharmacology & Therapeutics · 13

The lucent rim: a radiographic and computed tomography sign of Paget's disease of the skull

2006 · R. Brouard, M. Wybier, et al. · European Radiology · 9

Determination of SR 49059 in human plasma and urine by LC-APCI/MS/MS

1997 · Regina Burton, Michael Mummert, et al. · Journal of Pharmaceutical and Biomedical Analysis · 9

Tianeptine and its main metabolite. Disposition in chronic renal failure and haemodialysis

1990 · C. Salvadori, H. Merdjan, et al. · Fundamental and Clinical Pharmacology · 8

[Prevention of peritonitis during continuous ambulatory peritoneal dialysis. Value of disconnectable systems].

1988 · J Rottembourg, R Brouard, et al. · PubMed · 8

Evidence for an Involvement of Vasopressin in Mechanism of Primary Dysmenorrhea and Effect of the Non-Peptide Vasopressin V1a Receptor Antagonist, SR 49059, on the Uterus of Non-Pregnant Women

1998 · M. Åkerlund, T. Bossmar, et al. · Advances in experimental medicine and biology · 6

Transperitoneal movement and pharmacokinetics of cefotiam and cefsulodin in patients on continuous ambulatory peritoneal dialysis.

1988 · R Brouard, T N Tozer, et al. · PubMed · 6

Works count: 46

Citation count: 1,079

H-index: 16

I10-index: 19